Plain-English translation of NCT03568630 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →This research study is looking for early warning signs of pancreatic cancer by collecting blood samples from people who have a higher-than-average risk. Pancreatic cancer is very hard to detect early, which is why most cases are found too late for successful treatment. By studying blood markers in people at risk, researchers hope to develop better ways to catch this disease earlier, when treatment is more likely to work.
Pancreatic cancer is usually diagnosed very late because it doesn't cause obvious symptoms in the early stages. Most patients survive less than 5 years after diagnosis. Finding reliable blood markers could help doctors screen high-risk people and diagnose the disease sooner, which would dramatically improve survival rates.
You likely qualify if…
You likely don't qualify if…
You will be asked to visit the research center in Omaha, Nebraska twice per year to have blood samples drawn. These blood samples will be stored and analyzed to look for markers that might indicate early pancreatic cancer. The study is long-term, meaning you may be asked to participate for several years so researchers can track changes over time and see who develops pancreatic cancer and what warning signs appeared in their blood beforehand.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI), Virginia Mason Hospital/Medical Center
Enrollment target
~1,250 participants
Started
July 2018
Primary completion
July 2028
Age range
19 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Suzanne M Wessling, RN, BSN
University of Nebraska
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.